NEW Fogarty Funding Opportunities: Upcoming Deadlines
· NEW International Research Scientist Development Award (IRSDA) (K01) - Deadline March 1, 2010
Purpose: This program supports U.S. postdoctoral biomedical, epidemiological, clinical, social and behavioral scientists in the formative stages of their careers to conduct research in developing countries. These awards will support three- to five-years of “protected time” for mentored research and career development experiences, leading to an independent research career focused on global health.
Mechanism of Support: This FOA will utilize the K01 award mechanism.
· NEW Independent Scientist in Global Health Award (ISGHA) (K02) - Deadline March 1, 2010
Purpose: The purpose of the Independent Scientist Award in Global Health (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research in global health. The K02 award provides three, four, or five years of research and salary support, and “protected time” for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.
Below is the recently released research agenda/policy of the new NIH Director, Francis S. Collins, MD, PhD that includes this portion:
Focusing More on Global Health
Much of recent global health research has justifiably been focused on AIDS, tuberculosis, and malaria (11). It is also critical to go beyond the focus on the "big three" diseases to neglected tropical diseases of low-income countries that contribute to staggering levels of morbidity and mortality. In collaboration with other sources of support such as the Bill and Melinda Gates Foundation, NIH can play a major role in ramping up the discovery of novel targets in both pathogen and host and work to facilitate advances in prevention, diagnostics, and therapeutics. Helping to build capacity and training opportunities in the developing world will be a critical component of such progress. Additional resources will also be needed to respond to the growing challenge of chronic non-communicable diseases and injuries.
E. Ann Davis, DVM MPH MT(ASCP)
Scientific Review Officer
(On Detail from Fogarty International Center)
Population Sciences and Epidemiology (PSE) Integrated Review Group
Center for Scientific Review, NIH
6701 Rockledge Drive, Room 3137, MSC 7770
Bethesda, MD 20892-7770 (20817 for Fed Ex/delivery)